There are 81 new medicines that the European Medicines Agency (EMA) has recommended for placing on the market in 2016, 27 of which are new active ingredients: "Many of these innovative substances are based on the progress made in biomedical science and have the potential to make a difference for patients" specifies the Agency in its annual report for 2016<\/a>.<\/p>\n![\"Risultati](\"http:\/\/i.ebayimg.com\/00\/s\/NjAwWDYwMA==\/z\/1IYAAOSwLnBX2RXn\/$_35.JPG\")
In short, the European medicine cabinet is growing, human as a veterinarian. In fact, 11 medicines for animal use were also recommended for approval, including six new active substances. A third of these drugs prevent viral or bacterial infections in food-producing animals. About half of the companies that have received a positive opinion for their medicine have received scientific advice from the EMA during the development phase of their product. A fundamental tool to promote the collection of high quality data on the benefits and risks of medicines, as explained by the institution. But not only that, following the monitoring of the safety of all medicines marketed in the European Union (EU), the information on over 300 medicines for human use has been updated on the basis of new safety data.<\/p>\n